Explore more publications!

Health Monitor Monaco: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Monitor Monaco.

November 2025

December 2025

January 2026

Press releases published on January 7, 2026

LifeVantage Appoints Seasoned Technology Executive Mike Edwards as Chief Technology Officer to Drive Digital Innovation

January 7, 2026

LifeVantage Appoints Seasoned Technology Executive Mike Edwards as Chief Technology Officer to Drive Digital Innovation

GlobeNewswire

Phathom Pharmaceuticals Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

January 7, 2026

Phathom Pharmaceuticals Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

GlobeNewswire

Kiniksa Pharmaceuticals to Present at 44th Annual J.P. Morgan Healthcare Conference

January 7, 2026

Kiniksa Pharmaceuticals to Present at 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire

Genelux Corporation Announces Proposed Public Offering of Common Stock

January 7, 2026

Genelux Corporation Announces Proposed Public Offering of Common Stock

GlobeNewswire

Monte Rosa Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

January 7, 2026

Monte Rosa Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

GlobeNewswire

Phathom Pharmaceuticals Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results

January 7, 2026

Phathom Pharmaceuticals Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results

GlobeNewswire

Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF

January 7, 2026

Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF

GlobeNewswire

Bilan semestriel du contrat de liquidité DBV Technologies avec ODDO BHF

January 7, 2026

Bilan semestriel du contrat de liquidité DBV Technologies avec ODDO BHF

GlobeNewswire

Immuneering Announces Exceptional 64% Overall Survival At 12 Months in First-Line Pancreatic Cancer Patients Treated with Atebimetinib + mGnP

January 7, 2026

Immuneering Announces Exceptional 64% Overall Survival At 12 Months in First-Line Pancreatic Cancer Patients Treated with Atebimetinib + mGnP

GlobeNewswire

HyperCharge Health issues new statement calling for increased attention on Minnesota's Lyme Disease Crisis

January 7, 2026

HyperCharge Health issues new statement calling for increased attention on Minnesota's Lyme Disease Crisis

GlobeNewswire

Koelis Announces Designated CPT I Codes for Fusion Biopsy and Transperineal Biopsy in Prostate Cancer Diagnosis

January 7, 2026

Koelis Announces Designated CPT I Codes for Fusion Biopsy and Transperineal Biopsy in Prostate Cancer Diagnosis

GlobeNewswire

Ottimo Pharma Announces FDA Clearance of Investigational New Drug (IND) Application for OTP-01, a First-in-Class, Dual-Paratopic, Single-Agent, Anti-PD-1/VEGFR2 Antibody

January 7, 2026

Ottimo Pharma Announces FDA Clearance of Investigational New Drug (IND) Application for OTP-01, a First-in-Class, Dual-Paratopic, Single-Agent, Anti-PD-1/VEGFR2 Antibody

GlobeNewswire

Pinnacle Treatment Centers Appoints Brian Lantier as Chief Executive Officer

January 7, 2026

Pinnacle Treatment Centers Appoints Brian Lantier as Chief Executive Officer

GlobeNewswire

Pioneering Scientist Behind Revolutionary Weight-Loss Drugs and Leading Mathematician Honored with 2026 King Faisal Prize

January 7, 2026

Pioneering Scientist Behind Revolutionary Weight-Loss Drugs and Leading Mathematician Honored with 2026 King Faisal Prize

GlobeNewswire

Herantis Pharma - Phase 1b biomarker data show clear evidence of biological response to HER-096 in people with Parkinson's disease

January 7, 2026

Herantis Pharma - Phase 1b biomarker data show clear evidence of biological response to HER-096 in people with Parkinson's disease

GlobeNewswire

300 Exceptional Teen Scientists Recognized for Innovative STEM Research in Nation’s Oldest and Most Prestigious High School Competition

January 7, 2026

300 Exceptional Teen Scientists Recognized for Innovative STEM Research in Nation’s Oldest and Most Prestigious High School Competition

GlobeNewswire

$AB Science annonce un quatrième cas consécutif de réponse avec la combinaison d’AB8939 et du venetoclax dans le traitement de la leucémie myéloïde aiguë réfractaire ou en rechute, sur la base des données de phase 1$

January 7, 2026

AB Science annonce un quatrième cas consécutif de réponse avec la combinaison d’AB8939 et du venetoclax dans le traitement de la leucémie myéloïde aiguë réfractaire ou en rechute, sur la base des données de phase 1

GlobeNewswire

$AB Science reports fourth consecutive case of response from Phase 1 data for the combination of AB8939 with venetoclax for the treatment of refractory or relapsed acute myeloid leukemia$

January 7, 2026

AB Science reports fourth consecutive case of response from Phase 1 data for the combination of AB8939 with venetoclax for the treatment of refractory or relapsed acute myeloid leukemia

GlobeNewswire

GENFIT Announces 2026 Financial Calendar

January 7, 2026

GENFIT Announces 2026 Financial Calendar

GlobeNewswire

GENFIT annonce son calendrier financier pour 2026

January 7, 2026

GENFIT annonce son calendrier financier pour 2026

GlobeNewswire